Effects of cisplatin dose intensity on response and survival for patients with unresectable and untransplantable hepatocellular carcinoma: an analysis of 57 patients.
Carr
B I
BI
University of Pittsburgh, PA 15213, USA. carrbi@msx.upmc.edu
Dvorchik
I
I
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D002945:Cisplatin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004621:Embolization, Therapeutic; D005781:Gelatin Sponge, Absorbable / Q000627:therapeutic use; D006521:Hepatitis, Chronic / Q000150:complications; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008113:Liver Neoplasms / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D016019:Survival Analysis
D000970:Antineoplastic Agents; D002945:Cisplatin